TRAW Rallied 40% on Hantavirus Drug Candidate News — RTPR Had the Wire in 88ms
TRAW rallied 40% after announcing hantavirus drug candidates. RTPR delivered the GlobeNewswire release in 88ms at $1.84.
ERNA Spiked 92% on Breakthrough Cancer Data — RTPR Had the Wire in Under 500ms
ERNA spiked 92% on preclinical ovarian cancer results. RTPR delivered the GlobeNewswire release at $4, before the run to $7.70.
CMND Jumped 84% on Positive CMND-100 Trial Data — RTPR Had the Wire in 53ms
CMND jumped 84% after positive CMND-100 safety results. RTPR delivered the GlobeNewswire release in 53ms at $0.83 before the run to $1.53.
SILO Spiked 58% on European Patent Allowance for PTSD Therapy — RTPR Had the Wire in 91ms
SILO gained 58% after European patent news. RTPR delivered the GlobeNewswire release in 91ms at $0.36 before the run to $0.57.
AIM Rose 159% on Japan Patent Approval — RTPR Had the Wire in 92ms
AIM ImmunoTech gained 159% after Japan approved its cancer therapy patent. RTPR delivered the GlobeNewswire release in 92ms at $0.70.
RLMD Jumped 85% on Phase 2 Data and $160M Financing — RTPR Had the Wire in 246ms
RLMD jumped 85% on back-to-back press releases. RTPR delivered the wire in 246ms at $4.55 before the run to $8.45.